<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Santos LR</submitter><funding>Swiss National Science Foundation</funding><pagination>1302-1315</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6760180</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(9)</volume><pubmed_abstract>&lt;b>&lt;i>Background:&lt;/i>&lt;/b> Several single-nucleotide polymorphisms (SNPs) are known to increase the risk of Hashimoto's thyroiditis (HT); such SNPs reside in thyroid-specific genes or in genes related to autoimmunity, inflammation, and/or cellular defense to stress. The transcription factor Nrf2, encoded by &lt;i>NFE2L2&lt;/i>, is a master regulator of the cellular antioxidant response. This study aimed to evaluate the impact of genetic variation in &lt;i>NFE2L2&lt;/i> on the risk of developing HT. &lt;b>&lt;i>Methods:&lt;/i>&lt;/b&gt; In a case-control candidate gene association study, functional SNPs in the &lt;i>NFE2L2&lt;/i> promoter (rs35652124, rs6706649, and rs6721961) were examined either as independent risk factors or in combination with a previously characterized HT risk allele (rs28665122) in the gene &lt;i>SELENOS</pubmed_abstract><journal>Thyroid : official journal of the American Thyroid Association</journal><pubmed_title>Interaction of Genetic Variations in &lt;i>NFE2L2&lt;/i> and &lt;i>SELENOS&lt;/i> Modulates the Risk of Hashimoto's Thyroiditis.</pubmed_title><pmcid>PMC6760180</pmcid><funding_grant_id>153062</funding_grant_id><pubmed_authors>Habeos IG</pubmed_authors><pubmed_authors>Simoes MS</pubmed_authors><pubmed_authors>Ziros PG</pubmed_authors><pubmed_authors>Chartoumpekis DV</pubmed_authors><pubmed_authors>Sykiotis GP</pubmed_authors><pubmed_authors>Renaud CO</pubmed_authors><pubmed_authors>Bongiovanni M</pubmed_authors><pubmed_authors>Duraes C</pubmed_authors><pubmed_authors>Carvalho D</pubmed_authors><pubmed_authors>Soares P</pubmed_authors><pubmed_authors>Esteves C</pubmed_authors><pubmed_authors>Santos LR</pubmed_authors><pubmed_authors>Pestana A</pubmed_authors><pubmed_authors>Neves C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interaction of Genetic Variations in &lt;i>NFE2L2&lt;/i> and &lt;i>SELENOS&lt;/i> Modulates the Risk of Hashimoto's Thyroiditis.</name><description>&lt;b>&lt;i>Background:&lt;/i>&lt;/b> Several single-nucleotide polymorphisms (SNPs) are known to increase the risk of Hashimoto's thyroiditis (HT); such SNPs reside in thyroid-specific genes or in genes related to autoimmunity, inflammation, and/or cellular defense to stress. The transcription factor Nrf2, encoded by &lt;i>NFE2L2&lt;/i>, is a master regulator of the cellular antioxidant response. This study aimed to evaluate the impact of genetic variation in &lt;i>NFE2L2&lt;/i> on the risk of developing HT. &lt;b>&lt;i>Methods:&lt;/i>&lt;/b&gt; In a case-control candidate gene association study, functional SNPs in the &lt;i>NFE2L2&lt;/i> promoter (rs35652124, rs6706649, and rs6721961) were examined either as independent risk factors or in combination with a previously characterized HT risk allele (rs28665122) in the gene &lt;i>SELENOS</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2026-05-04T19:02:02.814Z</modification><creation>2019-10-11T07:10:50Z</creation></dates><accession>S-EPMC6760180</accession><cross_references><pubmed>31426718</pubmed><doi>10.1089/thy.2018.0480</doi></cross_references></HashMap>